Targeting BCL-2 With Venetoclax and Dexamethasone in Patients With Relapsed/Refractory T(11;14) Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Targeting BCL-2 With Venetoclax and Dexamethasone in Patients With Relapsed/Refractory T(11;14) Multiple Myeloma
Am. J. Hematol 2020 Dec 28;[EPub Ahead of Print], JL Kaufman, C Gasparetto, FH Schjesvold, P Moreau, C Touzeau, T Facon, LH Boise, Y Jiang, X Yang, F Dunbar, D Vishwamitra, S Unger, RNT Macartney, J Pesko, Y Yu, AH Salem, JA Ross, WJ Hong, PC Maciag, JM Pauff, S KumarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.